Recommendations for probiotic use in humans-a 2014 update.
Recommendations for probiotic use in humans-a 2014 update.
复制标题
DOI：
10.3390/ph7100999
复制
发表时间：
2014-10-10
期刊：
影响因子：
--
通讯作者：
Floch MH
中科院分区：
文献类型：
--
作者：
Floch MH
在过去的二十年里，益生菌在全球范围内得到了广泛的使用。然而，在某些临床条件下，哪种益生菌在哪种临床条件下使用仍然令人困惑。2005年，我们与哈佛联合在耶鲁大学召开了一次研讨会，邀请了一系列益生菌权威人士讨论并就常见临床条件下的使用建议得出结论;该研讨会于2008年和2011年再次召开。每一次，当局的人数都有所增加，并根据研究结果而有所不同。本文列出了从2011年更新的建议，并进行了修订，以使其在儿童和成人腹泻，腹泻相关性腹泻，坏死性小肠结肠炎，炎症性肠病，肠易激综合征，过敏性疾病和放射性肠炎中保持最新状态，等待我们第四届三年期耶鲁/哈佛研讨会于2015年召开。
Probiotics have gained worldwide use during the last two decades. However, which probiotic to use in which clinical condition has remained confusing in some clinical conditions. We convened a workshop at Yale in conjunction with Harvard in 2005, inviting a spectrum of probiotic authorities to discuss and reach conclusions on recommendations for use in common clinical conditions; the workshop was reconvened again in 2008 and in 2011. Each time the group of authorities was enlarged and varied depending on research studies. This article lists the recommendations updated from 2011 and is amended to bring it up to date in childhood and adult diarrhea, antibiotic-associated diarrhea, necrotizing enterocolitis, inflammatory bowel disorders, irritable bowel syndrome, allergic disorders, and radiation enteritis pending our 4th Triennial Yale/Harvard workshop to be convened in 2015.